139 related articles for article (PubMed ID: 19152069)
1. Peripheral quantitative computed tomography is useful to monitor response to alendronate therapy in postmenopausal women.
Sawada K; Morishige K; Nishio Y; Hayakawa J; Mabuchi S; Isobe A; Ogata S; Sakata M; Ohmichi M; Kimura T
J Bone Miner Metab; 2009; 27(2):175-81. PubMed ID: 19152069
[TBL] [Abstract][Full Text] [Related]
2. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
Sawada K; Morishige K; Ohmichi M; Nishio Y; Yamamoto T; Hayakawa J; Mabuchi S; Isobe A; Sasaki H; Sakata M; Tasaka K; Murata Y
Maturitas; 2007 Apr; 56(4):343-9. PubMed ID: 17010541
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover.
Burghardt AJ; Kazakia GJ; Sode M; de Papp AE; Link TM; Majumdar S
J Bone Miner Res; 2010 Dec; 25(12):2558-71. PubMed ID: 20564242
[TBL] [Abstract][Full Text] [Related]
4. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy.
Kendler DL; Roux C; Benhamou CL; Brown JP; Lillestol M; Siddhanti S; Man HS; San Martin J; Bone HG
J Bone Miner Res; 2010 Jan; 25(1):72-81. PubMed ID: 19594293
[TBL] [Abstract][Full Text] [Related]
5. The effect of alendronate on bone mass after distal forearm fracture.
van der Poest Clement E; Patka P; Vandormael K; Haarman H; Lips P
J Bone Miner Res; 2000 Mar; 15(3):586-93. PubMed ID: 10750574
[TBL] [Abstract][Full Text] [Related]
6. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.
Rizzoli R; Chapurlat RD; Laroche JM; Krieg MA; Thomas T; Frieling I; Boutroy S; Laib A; Bock O; Felsenberg D
Osteoporos Int; 2012 Jan; 23(1):305-15. PubMed ID: 21909729
[TBL] [Abstract][Full Text] [Related]
7. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal evaluation of the effects of alendronate on MRI bone microarchitecture in postmenopausal osteopenic women.
Folkesson J; Goldenstein J; Carballido-Gamio J; Kazakia G; Burghardt AJ; Rodriguez A; Krug R; de Papp AE; Link TM; Majumdar S
Bone; 2011 Mar; 48(3):611-21. PubMed ID: 21059422
[TBL] [Abstract][Full Text] [Related]
9. Alendronate increases bone density and bone strength at the distal radius in postmenopausal women.
Schneider PF; Fischer M; Allolio B; Felsenberg D; Schröder U; Semler J; Ittner JR
J Bone Miner Res; 1999 Aug; 14(8):1387-93. PubMed ID: 10457271
[TBL] [Abstract][Full Text] [Related]
10. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.
Naylor KE; Bradburn M; Paggiosi MA; Gossiel F; Peel NFA; McCloskey EV; Walsh JS; Eastell R
Osteoporos Int; 2018 Jun; 29(6):1407-1417. PubMed ID: 29525970
[TBL] [Abstract][Full Text] [Related]
11. Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis.
Qin L; Choy W; Au S; Fan M; Leung P
J Orthop Surg Res; 2007 May; 2():9. PubMed ID: 17511887
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the skeletal status by peripheral quantitative computed tomography of the forearm: short-term precision in vivo and comparison to dual X-ray absorptiometry.
Grampp S; Lang P; Jergas M; Glüer CC; Mathur A; Engelke K; Genant HK
J Bone Miner Res; 1995 Oct; 10(10):1566-76. PubMed ID: 8686514
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis.
Khanizadeh F; Rahmani A; Asadollahi K; Ahmadi MRH
Arch Endocrinol Metab; 2018 Aug; 62(4):438-445. PubMed ID: 30304108
[TBL] [Abstract][Full Text] [Related]
14. Multisite quantitative ultrasound: Colles' fracture discrimination in postmenopausal women.
Knapp KM; Blake GM; Fogelman I; Doyle DV; Spector TD
Osteoporos Int; 2002; 13(6):474-9. PubMed ID: 12107661
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Clin Rheumatol; 2007 Feb; 26(2):161-7. PubMed ID: 16565894
[TBL] [Abstract][Full Text] [Related]
16. Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.
Seeman E; Delmas PD; Hanley DA; Sellmeyer D; Cheung AM; Shane E; Kearns A; Thomas T; Boyd SK; Boutroy S; Bogado C; Majumdar S; Fan M; Libanati C; Zanchetta J
J Bone Miner Res; 2010 Aug; 25(8):1886-94. PubMed ID: 20222106
[TBL] [Abstract][Full Text] [Related]
17. Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass.
Felsenberg D; Bock O; Börst H; Armbrecht G; Beller G; Degner C; Stephan-Oelkers M; Schacht E; Mazor Z; Hashimoto J; Roth HJ; Martus P; Runge M
J Musculoskelet Neuronal Interact; 2011 Mar; 11(1):34-45. PubMed ID: 21364273
[TBL] [Abstract][Full Text] [Related]
18. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
[TBL] [Abstract][Full Text] [Related]
19. Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate.
Watts NB; Becker P
Bone; 1999 Jan; 24(1):65-8. PubMed ID: 9916786
[TBL] [Abstract][Full Text] [Related]
20. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.
Boutroy S; Bouxsein ML; Munoz F; Delmas PD
J Clin Endocrinol Metab; 2005 Dec; 90(12):6508-15. PubMed ID: 16189253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
